Trade Summary

3 days ago, Bonstein Sara, serving as CFO at Insmed Inc (INSM), sold 8,272 shares at $116.18 per share, for a total transaction value of $961,041.00. Following this transaction, Bonstein Sara now holds 71,486 shares of INSM.

This sale represents a 10.00% decrease in Bonstein Sara's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 13, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 15, 2026 at 4:08 PM ET, 2 days after the trade was made.

Insmed Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.